Literature DB >> 1102371

Toxic encephalopathy and acute brain-swelling in children.

J K Brown, A H Habel.   

Abstract

Problems in the diagnosis and management of children who present with an acute encephalopathic illness are examined. The aetiology, pathogenesis, pathology and clinical features of acute toxic encephalopathies are discussed, together with the differential diagnosis of those encephalopathies which are not induced by toxicity. Guidance is given on measures for the reduction of raised intracranial pressure and the management of defects of homeostasis. It is essential that facilities for intensive monitoring of these children be available during the acute phase of illness in order to reduce the number surviving with sequelae of mental and physical handicap.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1102371     DOI: 10.1111/j.1469-8749.1975.tb03538.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  5 in total

Review 1.  Interrelationships of liver and brain with special reference to Reye syndrome.

Authors:  J K Brown; H Imam
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Dangers of lumbar puncture.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-22

3.  The cerebral function analysing monitor in paediatric medical intensive care: applications and limitations.

Authors:  R C Tasker; S G Boyd; A Harden; D J Matthew
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

4.  Comparison of corticotropin-releasing factor, dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas.

Authors:  Maxim A Moroz; Ruimin Huang; Tatiana Kochetkov; Weiji Shi; Howard Thaler; Elisa de Stanchina; Idoia Gamez; Robert P Ryan; Ronald G Blasberg
Journal:  Clin Cancer Res       Date:  2011-03-08       Impact factor: 12.531

5.  Clinical features and prognosis of Reye's syndrome.

Authors:  J F Glasgow
Journal:  Arch Dis Child       Date:  1984-03       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.